Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1305 single-dose electrophysiology study in atrial flutter patients
2007-003455-36Phase 2Terminated
- Sponsor
- AstraZeneca
- Start
- Oct 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Atrial fibrillation (AFib) comparing AZD1305 intravenous infusion with Placebo intravenous infusion (2 arms). Primary endpoint: Left atrial effective refractory period. Started Oct 2007; status: terminated.
02
Drugs
AZD-1305
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2007-003455-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003455-36.